FierceBiotech 2026-02-03 Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges
FierceBiotech 2026-02-03 Pfizer's $10B monthly GLP-1 bet generates competitive weight loss in phase 2b
Endpoints News 2026-02-03 Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News 2026-02-03 Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
FierceBiotech 2026-01-21 Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ
BioPharma Dive 2026-01-12 JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year
FierceBiotech 2026-01-09 Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
Endpoints News 2026-01-08 French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
FierceBiotech 2025-12-09 Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug